|
Market Closed -
Nasdaq
16:00:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 4.925 USD | -2.18% |
|
+15.88% | -83.58% |
| 08-10 | Ernexa Therapeutics Announces Appointment of David Polinsky to Board of Directors | CI |
| 08-06 | Tranche Update on Ernexa Therapeutics Inc.'s Equity Buyback Plan announced on November 25, 2024. | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
ERNA 4.925 $
-2.18%
403K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ERNA | 4.925USD | -2.18% | 403K $ | |
CBOE
| ERNA | 5.030USD | -0.10% | 8.96K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 7.12 | 7.12 | 13.63 |
| Spread/Res. | -30.83% | -30.83% | -63.87% |
| Spread/Supp. | +50.15% | +50.15% | +50.15% |
| Support | 3.28 | 3.28 | 3.28 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ERNA Stock
- Charts Ernexa Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
